---
figid: PMC4688896__nihms744845f1
figtitle: Dysregulation and restoration of translational homeostasis in fragile X
  syndrome
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Gallus gallus
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Gallus gallus
- Danio rerio
pmcid: PMC4688896
filename: nihms744845f1.jpg
figlink: /pmc/articles/PMC4688896/figure/F1/
number: F1
caption: Normally, stimulation of cell surface receptors, including NMDA receptors
  (NMDARs) and group 1 metabotropic glutamate receptors (mGluRs; such as mGluR5),
  results in the activation of the phosphoinositide 3-kinase (PI3K),, mammalian target
  of rapamycin complex 1 (mTORC1; which comprises mTOR bound to regulatory-associated
  protein of mTOR (RAPTOR)) and extracellular signal-regulated kinase (ERK)signalling
  pathways in neurons. mTORC1 phosphorylates eukaryotic initiation factor 4E (eIF4E)
  binding proteins (4E-BPs), including 4E-BP2, the predominant 4E-BP isoform in the
  mouse brain, which derepresses eIF4E to promote ‘cap’-dependent translation. mTORC1
  also phosphorylates and activates p70 S6 kinase 1 (S6K1), which phosphorylates ribosomal
  protein S6 and eIF4B. Phosphorylation of eIF4B by S6K1 stimulates the helicase activity
  of eIF4A to promote cap-dependent translation. mTORC1-dependent translation is triggered
  upstream by a signalling pathway involving PI3K, 3-phosphoinositide-dependent protein
  kinase 1 (PDK1) and/or PDK2, AKT, tuberous sclerosis 1 (TSC1) and/ or TSC2 and RAS
  homologue enhanced in brain (RHEB). ERK phosphorylates and activates MAP kinase-interacting
  serine/threonine-protein kinases (MNKs), which phosphorylate eIF4E to promote translation.
  This ERK-dependent translation is triggered upstream by a pathway involving RAS,
  RAF and MAPK/ERK kinase 1 (MEK1). mGluR5 signals to the PI3K–AKT–mTORC1 pathway
  via HOMER1A, SH3 and multiple ankyrin repeat domains (SHANK) proteins and PI3K enhancer
  (PIKE), and NMDARs signal to ERK via postsynaptic density protein 95 (PSD95). The
  protein levels of several targets of the RNA-binding protein fragile X mental retardation
  protein (FMRP), are increased in fragile X syndrome (FXS). The increased expression
  of these proteins results in basally elevated PI3K, mTORC1 and ERK signalling and
  thus increased translation. m7G, 7-methyl-guanosine; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate;
  PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate; UTR, untranslated region.
  Adapted from REF. , Nature Publishing Group.
papertitle: Dysregulation and restoration of translational homeostasis in fragile
  X syndrome.
reftext: Joel D. Richter, et al. Nat Rev Neurosci. ;16(10):595-605.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9628292
figid_alias: PMC4688896__F1
figtype: Figure
redirect_from: /figures/PMC4688896__F1
ndex: 634715bb-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4688896__nihms744845f1.html
  '@type': Dataset
  description: Normally, stimulation of cell surface receptors, including NMDA receptors
    (NMDARs) and group 1 metabotropic glutamate receptors (mGluRs; such as mGluR5),
    results in the activation of the phosphoinositide 3-kinase (PI3K),, mammalian
    target of rapamycin complex 1 (mTORC1; which comprises mTOR bound to regulatory-associated
    protein of mTOR (RAPTOR)) and extracellular signal-regulated kinase (ERK)signalling
    pathways in neurons. mTORC1 phosphorylates eukaryotic initiation factor 4E (eIF4E)
    binding proteins (4E-BPs), including 4E-BP2, the predominant 4E-BP isoform in
    the mouse brain, which derepresses eIF4E to promote ‘cap’-dependent translation.
    mTORC1 also phosphorylates and activates p70 S6 kinase 1 (S6K1), which phosphorylates
    ribosomal protein S6 and eIF4B. Phosphorylation of eIF4B by S6K1 stimulates the
    helicase activity of eIF4A to promote cap-dependent translation. mTORC1-dependent
    translation is triggered upstream by a signalling pathway involving PI3K, 3-phosphoinositide-dependent
    protein kinase 1 (PDK1) and/or PDK2, AKT, tuberous sclerosis 1 (TSC1) and/ or
    TSC2 and RAS homologue enhanced in brain (RHEB). ERK phosphorylates and activates
    MAP kinase-interacting serine/threonine-protein kinases (MNKs), which phosphorylate
    eIF4E to promote translation. This ERK-dependent translation is triggered upstream
    by a pathway involving RAS, RAF and MAPK/ERK kinase 1 (MEK1). mGluR5 signals to
    the PI3K–AKT–mTORC1 pathway via HOMER1A, SH3 and multiple ankyrin repeat domains
    (SHANK) proteins and PI3K enhancer (PIKE), and NMDARs signal to ERK via postsynaptic
    density protein 95 (PSD95). The protein levels of several targets of the RNA-binding
    protein fragile X mental retardation protein (FMRP), are increased in fragile
    X syndrome (FXS). The increased expression of these proteins results in basally
    elevated PI3K, mTORC1 and ERK signalling and thus increased translation. m7G,
    7-methyl-guanosine; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate; PtdIns(3,4,5)P3,
    phosphatidylinositol-3,4,5-trisphosphate; UTR, untranslated region. Adapted from
    REF. , Nature Publishing Group.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nmdar2
  - Nmdar1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Prosap
  - dlg1
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Pdk1
  - Dsor1
  - Mtk
  - Akt
  - gig
  - Tsc1
  - Erk7
  - rl
  - Rheb
  - eIF4B
  - eIF4A
  - CG7483
  - lok
  - eIF4G2
  - eIF4G1
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - E(spl)mgamma-HLH
  - Mtor
  - Tor
  - raptor
  - Fmr1
  - Grm5
  - Grin1
  - Pik3r1
  - Agap2
  - Dlg4
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Pdpk1
  - Mdk
  - Pdk2
  - Akt1
  - Tsc2
  - Ephb2
  - Mapk1
  - Eif4b
  - Atp7a
  - Eif4e
  - Eif4ebp2
  - Rptor
  - Uts2r
  - Alpha-re
  - GRM5
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AGAP2
  - HOMER1
  - SHANK2
  - DLG4
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDPK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PDK2
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - EPHB2
  - MAPK1
  - MAPK3
  - RHEB
  - RHEBP1
  - EIF4B
  - EIF4A1
  - EIF4A2
  - EIF4A3
  - ATP7A
  - EIF4G1
  - EIF4G2
  - EIF4G3
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EIF4EBP2
  - MTOR
  - UTS2R
  - SLC14A2
  - FMR1
  - rab1ab
  - pdk1
  - pdk2b
  - tsc2
  - tsc1b
  - rheb
  - rhebl1
  - eif4bb
  - eif4ba
  - eif4e1b
  - eif4ea
  - mtor
  - PtdIns(3,4,5)P
  - Glutamate
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
